期刊文献+

孕激素受体B亚型在子宫内膜癌细胞中的功能 被引量:2

Functional study of progesterone receptor isoforms in endometrial cancer cell lines
下载PDF
导出
摘要 目的:通过反义寡核苷酸(antisense oligodeoxynucleotide,AS-ODN)技术特异性下调子宫内膜癌细胞系中孕激素受体亚型B(progestrone receptor isoform B,PR-B),在此基础上观察激素对转染前后细胞作用的改变,了解子宫内膜癌细胞中孕激素受体亚型功能的不同。方法:体外培养高分化子宫内膜癌细胞Ishikawa和中分化子宫内膜癌细胞Hec-1B,转染PR-B的反义寡核苷酸和正义寡核苷酸及错义寡核苷酸后,提取细胞蛋白,采用Western blot方法测定各个条件下内膜癌细胞中两种孕激素受体亚型的表达;并在转染PR-B的反义寡核苷酸和正义寡核苷酸及错义寡核苷酸后,用MTT法测定转染前后各种激素对细胞生长作用的改变。结果:转染孕激素受体亚型PR-B的反义寡核苷酸后,两种细胞系PR-B的表达较非转染组显著下调,孕激素受体亚型A(progesterone receptor isoformA,PR-A)的表达无明显变化。雌激素(17β-estradiol,E2)作用后72h Ishikawa细胞生长显著高于对照组,Hec-1B细胞较对照组有升高趋势,但差异无统计学意义。孕激素(R5020)作用72h后对Ishikawa细胞有显著抑制作用,96h后对Hec-1B细胞有显著抑制作用。在雌、孕激素作用基础上加入米非司酮(mifepristone,RU486),96h后Ishikawa细胞明显增生,而仅48h后HEC-1B细胞明显增生。转染PR-B的反义寡核苷酸后,雌激素对内膜癌细胞生长的刺激作用较转染前增强,孕激素对细胞的生长抑制作用减弱甚至消失,米非司酮拮抗孕激素的作用较转染前显著降低。结论:(1)向子宫内膜癌细胞系中转染PR-B的反义寡核苷酸可以下调PR-B的表达,使细胞优势表达PR-A;(2)雌激素可以刺激内膜癌细胞的生长,PR-B可能参与下调雌激素对内膜癌细胞的促生长作用;(3)孕激素在雌激素基础上抑制内膜癌细胞的生长,主要可能通过PR-B起抗内膜癌细胞增生作用;(4)米非司酮有拮抗孕激素抑制子宫内膜癌细胞生长的作用。PR-B可能参与介导了米非司酮拮抗孕激素的作用。 Objective:To study the functional differences between the two progestrone receptor isoforms ( PR-A and PR-B ) in human endometrial cancer, using antisense oligodeoxynucleotide(AS-ODN) to downregulate isoform B of progestrone receptor in endometrial carcinoma cell lines, After transfection of the oligodeoxynucleotide, several kinds of hormones were added in the cells to observe the different response, whereh to study the functional differences between the two isoforms. Methods: The well-differentiated endometrial cancer cell line Ishikawa and moderate-differentiated endometrial cancer cell line Hec- 1B were cuhrued in vitro. The cells were transfected with antisense, sense, and scramble-ODN. After 48 hours, the expressions of two progesterone receptor isoforms were detected by Western blot using specific antibody. Then the cells were planted in 96-well plates, transfected with antisense, sense, scramble- ODN and added in several hormones to search for the response in distinct hormones and oligodeoxynucleotides. Results: After transfecting antisense-ODN, two cell lines were down-regulated in progesterone receptor isoform B, but progesterone receptor isoform A was not down-regulated, and the progesterone receptor isoform B of cells transfected with sense and scramble-ODN was not changed. When stimulated by 17β-estradiol(E2) for 72 hours, the growth of Ishikawa cells was significantly higher than that of the control, Hec-1B cells only grew higher than control, but it was to significant in statistics. R5020 inhibited Ishikawa cells significantly after stimulating for 72 hours. There was the same effect in Hec-1B cells after stimulating for 96 hours. On the bases of E2 and R5020, we added mifepristone(RU486) . The cells developed after 96 hours in Ishikawa cells and developed after 48 hours in Hec-1B cells. When PR-B was down-regulated, the stimulating effect of E2 was enhanced, but the inhibitory effect of R5020 was decreased, RU486 antagonized R5020 weaklier than the control. Conclusion: AS-ODN directed against the human PR-B can inhibit the expression of PR-B effectively, through which the PR-A expresses predominantly. E2 can cause endometrial carcinoma cell growth, PR-B is associated with the stimulating effect of E2 in endometrial carcinoma cells. Progestin (R5020) inhibits the hyperplasia induced by E2, PR-B is involved in the inhibitory effect of R5020. RU486 antagonizes the effect of R5020, inhibiting cell growth, PR-B is involved in the antagonizing effect of RU486.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2006年第5期475-479,共5页 Journal of Peking University:Health Sciences
基金 国家自然科学基金(30170977)资助~~
关键词 子宫内膜肿瘤 受体 雌激素 寡核苷酸类 反义 Endometrial neoplasms Receptors, eserogen Oligonucleotides, antisense
  • 相关文献

参考文献9

  • 1Kastner P,Krust A,Trcotte B,et al.Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B[J].EMBO J,1990,9:1603-1614.
  • 2Lamb C,Simian M,Molinolo A,et al.Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro:progesterone receptor involvement in serum or growth factor-induced cell proliferation[J].J Steroid Biochem Mol Bio,1999,70:133-142.
  • 3Dai D,Kumar NS,Wolf DM,et al.Molecular tools to reestablish progestin control of endometrial cancer cell proliferation[J].Am J Obstet Gynecol,2001,184:790-797.
  • 4Izant J,Weintraub HH.Inhibition of thymidine kinase gene expression by antisense RNA:A molecular approach to genetic analysis[J].Cell,1984,36:1007.
  • 5Kraus WL,Weis KE,Katzenellenbogen BS,et al.Inhibitory cross-talk between steroid hormone receptors:different targeting of estrogen receptor in the repression of its transcriptional activity bu agonist-and antagonist-occupied progestin receptors[J].Mol AND Cellulatr Bio,1995,15:1847-1857.
  • 6Arnett-Mansfield RL,deFazio A,Wain GV,et al.Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium[J].Cancer Res,2001,61:4576-4582.
  • 7Smid-koopman E,Blok LJ,Kuhne LC,et al.Distinct functional differences of human progesterone receptor A and B on gene expression and growth regulation in two endometrial carcinoma cell lines[J].J Soc Gynecol Investig,2003,10:49-157.
  • 8陆叶,于丽,陈春玲,廖秦平.雌、孕激素和米非司酮对子宫内膜癌细胞的作用[J].北京大学学报(医学版),2005,37(3):284-286. 被引量:9
  • 9Sun X,Christow A,Marions L,et al.Progestrone receptor isoform B in the human fallopian tube and endometrium following mifepristone[J].Contraception,2003,67:319-326.

二级参考文献13

  • 1曹泽毅.中华妇产科学(第1版)[M].北京:人民卫生出版社,1999.35-37.
  • 2Castro-Rivera E , Wormke M, Safe S. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells[J]. Mol Cell Endocrinol, 1999,150 : 11 - 21
  • 3Dai D, Kumat NS, Wolf DM, et al. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation [ J ]. Am J Obstet Gynecol ,2001, 184:790 - 797
  • 4Ehrlich CE, Young PC, Stehman FB, et al. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium[J]. Am J Obstet Gynecol, 1988, 158:796-807
  • 5Niwa K , Morishita S, Murase T , et al. Inhibitory effects of medroxy progesterone acetate on mouse endometrial carcinogenesis [ J ].Jpn J Cancer Res , 1995,86:724 - 729
  • 6Okada H. Progestogen therapy in the treatment of endometrial cancerclinical results and mechanism of steroid action[ J ]. Gan To Kagaku Ryoho ,1988 , 15 (4 pt 2-1 ) :924 -928
  • 7Meyer ME, Pornon A, Ji JW, et al. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor[J]. EMBO J, 1990 ,9:3923 -3932
  • 8Kimura T, Azuma C,Saji F,et al. The biological effects of macrophage -colony -stimulating factor induced by progestin on growth and differentiation of endometrial adenocarcinoma cells[ J]. Int J cancer ,1991 ,49:229-233
  • 9Terakawa N, Shimizu I, Tanizawa O , et al. RU486 , a progestin antagonist , binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins[ J].J Steroid Biochem, 1988,31: 161 - 166
  • 10Meyn RE, Stephens LC, Hunter NR,et al. Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas[J]. Int J Cancer, 1995, 60:725 -729

共引文献8

同被引文献16

  • 1廖秦平,郑虹.孕激素受体A和B亚型在子宫内膜癌中的临床意义[J].北京大学学报(医学版),2004,36(6):616-619. 被引量:4
  • 2范剑虹,吴霞,何陈云.中晚期宫颈癌的同步放化疗[J].中国临床医学,2006,13(6):983-984. 被引量:17
  • 3Kitawakil J, Obayashi H, Ishiharal H, et al. Oestrogen receptor- alpha gene polyrnorphism is associated with endometriosis, adenomyosis and leiomyomata[J ]. Human Reproduction, 2001, 16: 51.
  • 4Bergholt T, Erikser L, Berendt N, et al. Prevalence and risk factors of adenomyosis at hysterectomy[J]. Human Reproduction, 2001, 16: 2418.
  • 5ItoT, Tachibana M, Yamamoto S, et al. Expression of estrogen receptor (ER - alpha and ER - beta) mRNA in human prostate cancer[J]. Eurllro, 2001, 40: 557,.
  • 6Frasor J, Barnett D H, Danes J M, et al. Response - specific and ligand dose - dependent modulation of estrogen receptor (ER) alpha activity by ER beta in the uterus[J]. Endocrinology, 2003, 144: 3159.
  • 7曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2004.2170-2172.
  • 8Horwitz KB,Tung L. Tati moto GS. Novel. mechanisms of anti progestin action[J ]. Acts Oncol, 1996,35 : 129-140.
  • 9Amett-Mansfield RL,De Fazio A,Wain GV, et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium[J]. Cancer Res, 2001,61: 4576- 4582.
  • 10Mcgowan EM, Clarke CL. Effect of over expression of progesterone receptor A on endogenous progestin-senstive endpoints in breast cancer cells. Mol Endocrinol, 1999, 13: 1657-1671.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部